Package 42806-061-01

{"route": ["ORAL"], "spl_id": "8cd322df-f304-482e-9ed5-a7afa26f5645", "openfda": {"nui": ["N0000000160", "N0000008836", "M0001335", "N0000175722", "N0000175578", "N0000008832"], "upc": ["0342806061015"], "unii": ["R16CO5Y76E", "C1ENJ2TE6C"], "rxcui": ["848768"], "spl_set_id": ["3292a7c6-5ba3-4563-bc62-e43040634123"], "pharm_class_cs": ["Anti-Inflammatory Agents, Non-Steroidal [CS]"], "pharm_class_pe": ["Decreased Prostaglandin Production [PE]", "Decreased Platelet Aggregation [PE]"], "pharm_class_epc": ["Nonsteroidal Anti-inflammatory Drug [EPC]", "Platelet Aggregation Inhibitor [EPC]"], "pharm_class_moa": ["Cyclooxygenase Inhibitors [MoA]"], "manufacturer_name": ["Epic Pharma, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET in 1 BOTTLE (42806-061-01)", "package_ndc": "42806-061-01", "marketing_start_date": "20200630"}], "brand_name": "Oxycodone and Aspirin", "product_id": "42806-061_8cd322df-f304-482e-9ed5-a7afa26f5645", "dosage_form": "TABLET", "pharm_class": ["Anti-Inflammatory Agents", "Non-Steroidal [CS]", "Cyclooxygenase Inhibitors [MoA]", "Decreased Platelet Aggregation [PE]", "Decreased Prostaglandin Production [PE]", "Full Opioid Agonists [MoA]", "Nonsteroidal Anti-inflammatory Drug [EPC]", "Opioid Agonist [EPC]", "Platelet Aggregation Inhibitor [EPC]"], "product_ndc": "42806-061", "dea_schedule": "CII", "generic_name": "Oxycodone and Aspirin", "labeler_name": "Epic Pharma, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Oxycodone and Aspirin", "active_ingredients": [{"name": "ASPIRIN", "strength": "325 mg/1"}, {"name": "OXYCODONE HYDROCHLORIDE", "strength": "4.8355 mg/1"}], "application_number": "ANDA040910", "marketing_category": "ANDA", "marketing_start_date": "20200630", "listing_expiration_date": "20261231"}